When does Ping An Healthcare (1833.HK) report earnings?

Ping An Healthcare (1833.HK) is scheduled to report earnings on **18 Feb 2026**. Expect revenue growth and margin guidance to be the main drivers of the market reaction.

What is the current valuation of 1833.HK stock?

As of 17 Feb 2026 pre-market, 1833.HK stock trades at **HK$13.91** with a trailing PE of **142.10** and PB of **2.51**, indicating a premium valuation versus sector averages.

What price targets should investors watch for 1833.HK stock?

Meyka AI shows short-term **HK$14.06**, quarterly **HK$18.56**, and yearly **HK$21.99** forecasts. These are model projections and not guarantees; monitor earnings and guidance for updates.

What are the main risks for 1833.HK stock after earnings?

Main risks include weaker-than-expected online patient growth, margin pressure from product mix, and regulatory shifts in China. High valuation amplifies downside on negative surprises.

HK Stocks

Ping An Healthcare (1833.HK, HKSE) HK$13.91 pre-market ahead of earnings: guidance key

ByDanny Kontos February 17, 2026

We see 1833.HK stock at HK$13.91 in Hong Kong pre-market on 17 Feb 2026, with earnings due 18 Feb 2026. The main market focus is on revenue growth and margin guidance from Ping An Healthcare and Technology Company Limited (1833.HK) on the HKSE. Investors will weigh near-term guidance against a stretched valuation, with a trailing PE near 142.10 and EPS of 0.10. Volume is light at 1,375,492 shares today, and the stock sits between its 50-day average HK$15.02 and 200-day average HK$13.57.